Earnings Performance - Tilray's stock dropped 12% after missing analyst sales forecasts, reporting 211millioninrevenuecomparedtotheexpected216.3 million for Q2 FY2025 [1] - Despite the revenue miss, the company achieved a 9% year-over-year revenue growth, reaching a record 211millionforQ2[2]−Adjustedearningsbrokeeven,outperformingtheforecasted0.01 per share loss, but GAAP results showed a net loss of 85million,or0.10 per share, which is nearly 50% worse than the previous year's Q2 loss of 0.07pershare[4][5]BusinessSegmentPerformance−Internationalcannabissalesgrew2566 million, despite the strong growth in international cannabis sales [2] Company Outlook - Tilray has consistently reported losses over the past six years and is expected to continue losing money in the coming years [5] - The company's inability to achieve profitability raises concerns about its stock being a viable investment [5]